Drug & intervention
sarilumab
RxCUI 1923319
RxNorm ingredient and formulation relationships
Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.
Loading RxNorm relationships…
Clinical trials
13 shownA Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)NCT07154290 · 2026-03-18
RECRUITINGTreatment of Rheumatoid Arthritis With DMARDs: Predictors of ResponseNCT03414502 · 2007-12-10
RECRUITINGInterleukin-6 Inhibitors and Drug-drug Interactions in Patients With Rheumatoid ArthritisNCT04842981 · 2021-05-25
TERMINATEDMeasurement of the Structural Efficacy in Active RA Patients Treated With Sarilumab in Combination With MTX and Naive to BiologicsNCT03535402 · 2018-06-01
UNKNOWNEffect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid ArthritisNCT03449758 · 2018-03-05
COMPLETEDA Study Assessing the Safety and Efficacy of Sarilumab Added to Non-MTX DMARDs or as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis (SARIL-RA-HARUKA)NCT02373202 · 2015-02-01
COMPLETEDEfficacy and Safety of Sarilumab and Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (SARIL-RA-MONARCH)NCT02332590 · 2015-01-28
COMPLETEDTo Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid ArthritisNCT02057250 · 2014-03-01
COMPLETEDSingle-dose Study to Describe the Pharmacodynamics (PD) and Safety of Sarilumab (REGN88/SAR153191) and Tocilizumab in Adults With Rheumatoid Arthritis (RA)NCT02097524 · 2014-03-01
COMPLETEDAn Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus MethotrexateNCT01764997 · 2013-04-01
TERMINATEDTo Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)NCT01709578 · 2012-10-01
COMPLETEDEffect of SAR153191 (REGN88) With Methotrexate in Patients With Active Rheumatoid Arthritis Who Failed TNF-α BlockersNCT01217814 · 2010-11-01
TERMINATEDEvaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis PatientsNCT01061736 · 2010-03-01
COMPLETEDConditions being studied
Research locations
Leading sponsors
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.